COMPARATIVE EVALUATION OF EFFICACY AND SAFETY PROFILE OF INTRAVENOUS FERRIC CARBOXYMALTOSE VERSUS IRON SUCROSE IN ADULT PATIENTS WITH SEVERE IRON DEFICIENCY ANAEMIA

Subhashree Kar0 个研究点目标入组 0 人开始时间: 待定最近更新: 2023年10月16日

试验速览

暂无简介。

•1.Age 18 years and above of either sex.
•2.All diagnosed patients of severe IDA, attending Clinical Haematology & Medicine Department of SCB Medical College and Hospital, Cuttack.
•3.TSAT Levels less than 30%
•4.He/She must be willing to comply to study protocol till the end of the trial.
•5.He/She is willing to give written informed consent at the baseline visit.
•6.All patients will be provided with patient information sheet regarding all pros and cons of the study at the baseline visit.

•1.Age <18 years
•2.Pregnant and Lactating women
•3.Anemia due to any other cause other than IDA
•4.Patients with known history of hypersensitivity to iv Iron injection
•5.Patients with iron treatment or blood transfusion within 4weeks prior to treatment
•6.Patients with recent history of treatment with Erythropoetin.

发起方

Subhashree Kar